Concentrations of soluble ST2 predict the long-term outcome of beta-Blocker therapy in patients with ST-Elevation Myocardial Infarction

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-15006264

Enrollment

Unknown

Registered

2015-04-15

Start date

2015-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-Elevation Myocardial Infarction

Interventions

one:beta-Blocker therapy

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients must meet the following criteria for study entry: 1) Aged 18 to 75 years old; 2) admitted with AMI in the 1 to 7 days before enrollment; 3) able to provide written,informed consent;

Exclusion criteria

Exclusion criteria: 1. Chronic Heart Failure; 2. Serious infections; Systemic inflammatory response syndrome; 3. Severe hepatic insufficiency (liver cirrhosis, liver fibrosis); 4. Severe renal insufficiency defined as serum creatinine >2.5 mg/dl; 5. Connective tissue diseases; 6. History of malignancy; 7. pregnancy

Design outcomes

Primary

Measure	Time frame
all-cause mortality;Cardiac death;heart failure;recurrent myocardial infarction;	—

Countries

China

Contacts

Public ContactHe Lei

helei0528@126.com+86 18040505199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026